- B2B & Professional Services
- Consumer Goods
- Education & Training
- Energy & Utilities
- Engineering, Construction & Real Estate
- Financial Services
- Industrials & Manufacturing
- Logistics & Transportation
- Primary Industries
- Private Equity
- Public & Social Sector
- TMT (Telecoms, Media, Technology)
- Travel, Leisure & Hospitality
Pharma & Healthcare
Our clients, ranging from international pharma majors to biotech scale-ups, medical devices and providers of primary and secondary care, all operate in highly regulated markets with often complex payer-provider landscapes. Leveraging a deep knowledge of this specific context, we support our clients in strategic growth projects as well as initiatives aimed at commercial and operational improvement.
Related case studies
Post-merger integration of two pharmacy chains
Integrated two pharmacy chains in continental Europe, delivering a smooth transition and almost double the targeted synergies.
With our seasoned consultants leading client teams, we designed and delivered the integration across all functions, with minimal disruption to operations, successfully bringing together competitors into one organisation. The integration ran on target, and far exceeded financial expectations. Today, the client is developing its next phase of growth, with our support.
Strategy development for a specialist UK hospital
For a UK hospital specialised in neuro-disability, developed a strategy to deliver best-in-field treatment nationally and double in size.
Working closely with the CEO and his leadership team, we identified strategic options, evaluated them against criteria such as market positioning, critical success factors, financial impact and ease of implementation, and developed a 5-year action plan based on the strategic option selected: to embark upon an ambitious transformation from local specialist hospital, to national service and centre of excellence.
Growth potential in diagnostics & outpatient services
Detailed a compelling growth story for a European healthcare provider, leading a minority investor to acquire the company.
We examined expansion opportunities within and beyond the company’s existing footprint of geographies, services, and modalities. This included assessing the impact of disruptive technologies, and evaluating the best routes to realizing the opportunities, whether organically or through M&A and partnerships. The investor acquired the company outright on the strength of our findings, and the growth plan was implemented, driving significant value.
Distribution optimisation for a global biotech firm
Assessed optimal pharma distribution models across key markets for a global biotech firm, enabling new partnerships and renegotiations.
For our client, a rare disease biotech nearing end-of-contract with its local distribution partners in several Middle Eastern and African markets, we evaluated the best distribution models per market, and determined the range of market rates for different types of distribution services. This supported the client to optimise its models in each market, including renegotiating compensation terms, and replacing partners.
Far-reaching strategy for a healthcare NGO
Supported this frontline healthcare charity to define and agree the 5-year strategy to maximise their impact
Our consultants developed a focused strategy that would enable greater impact with fewer resources, through intense focus. The clear and grounded strategy was ratified by trustees and management, and is now being implemented.
Transforming digital services in consumer health
Supported a consumer health products player to develop and integrate D2C digital health services
Working closely with a client team, we developed a focused strategy to build on existing innovations in digital solutions with clear choices on where to play, how to win, and the operating model changes required, underpinning competitive strength and sustainable growth.